Viatris Discloses Positive Data From 2 Drugs In Earnings Report, Stock Soars

benzinga.com/25/05/45297381/viatris-shares-positive-data-from-investigational-contraceptive-patch-fast-acting-meloxicam-reduces-opioid-use-in

Viatris Inc. (NASDAQ:VTRS) on Thursday, released data from Phase 3 study evaluating the contraceptive efficacy and safety of XULANE LO low dose weekly dermal patch of 150 mcg norelgestromin and 17.5 mcg ethinyl estradiol per day in women of childbearing potential.
In this study, XULANE LO…

This story appeared on benzinga.com, 2025-05-08 18:55:36.
The Entire Business World on a Single Page. Free to Use →